Journal of the American Academy of Child and Adolescent Psychiatry
-
Publication Venue For
-
1.79 Parental Supervision Positively Impacts Their Children’s Income Two Decades Later.
61:S166-S167.
2022
-
PARENT MANAGEMENT TRAINING WORKSHOP.
61:S338-S339.
2022
-
Designing Culturally and Contextually Sensitive Protocols for Suicide Risk in Global Mental Health: Lessons From Research With Adolescents in Kenya..
61:1074-1077.
2022
-
6.14 Randomized, Placebo-Controlled Trial With Open-Label Extension of Intranasal Oxytocin for Autism Spectrum Disorder.
60:S162-S162.
2021
-
Editorial: Shedding Light on the Early Neurobiological Roots of Infant Temperament and Risk for Anxiety..
60:1069-1071.
2021
-
Polygenic Risk and the Course of Attention-Deficit/Hyperactivity Disorder From Childhood to Young Adulthood: Findings From a Nationally Representative Cohort..
60:1147-1156.
2021
-
Identifying Adolescents at Risk for Depression: A Prediction Score Performance in Cohorts Based in 3 Different Continents..
60:262-273.
2021
-
Amygdala Functional Connectivity Is Associated With Emotion Regulation and Amygdala Reactivity in 4- to 6-Year-Olds..
60:176-185.
2021
-
Borderline Symptoms at Age 12 Signal Risk for Poor Outcomes During the Transition to Adulthood: Findings From a Genetically Sensitive Longitudinal Cohort Study..
59:1165-1177.e2.
2020
-
Editorial: How Badly Do We Undercount Chronic Maltreatment, and How Much Should Clinicians Care?.
58:1152-1153.
2019
-
Adolescent Victimization and Self-Injurious Thoughts and Behaviors: A Genetically Sensitive Cohort Study..
58:506-513.
2019
-
Trajectories of Alcohol Initiation and Use During Adolescence: The Role of Stress and Amygdala Reactivity..
57:550-560.
2018
-
From Childhood Conduct Problems to Poor Functioning at Age 18 Years: Examining Explanations in a Longitudinal Cohort Study..
57:54-60.e4.
2018
-
Single Nucleotide Polymorphism Heritability of a General Psychopathology Factor in Children..
55:1038-1045.e4.
2016
-
Social isolation and mental health at primary and secondary school entry: a longitudinal cohort study..
54:225-232.
2015
-
How evidence on the developmental nature of attention-deficit/hyperactivity disorder can increase the validity and utility of diagnostic criteria..
53:723-725.
2014
-
Disrupted amygdala reactivity in depressed 4- to 6-year-old children..
52:737-746.
2013
-
Findings from the Pittsburgh Youth Study: cognitive impulsivity and intelligence as predictors of the age-crime curve..
51:1136-1149.
2012
-
Relational aggression in children with preschool-onset psychiatric disorders..
51:889-901.
2012
-
Functional connectivity of the amygdala in early-childhood-onset depression..
50:1027-41.e3.
2011
-
A discordant monozygotic twin design shows blunted cortisol reactivity among bullied children..
50:574-582.e3.
2011
-
Corrigendum.
50:313-313.
2011
-
Serotonin transporter gene moderates the development of emotional problems among children following bullying victimization..
49:830-840.
2010
-
Implications of Extending the ADHD Age-of-Onset Criterion to Age 12.
49:210-216.
2010
-
Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS)..
49:132-140.
2010
-
Use of Antidepressants in Children: Is It Time for a Comparative Effectiveness Trial? Deputy Editor's Comment.
49:186-188.
2010
-
Randomized controlled trial of a paraprofessional-delivered in-home intervention for young reservation-based American Indian mothers..
48:591-601.
2009
-
School, neighborhood, and family factors are associated with children's bullying involvement: a nationally representative longitudinal study..
48:545-553.
2009
-
Imaging genetics..
48:356-361.
2009
-
Psychopharmacological treatment for very young children: contexts and guidelines..
46:1532-1572.
2007
-
Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS)..
46:1642-1650.
2007
-
Childhood behavior problems linked to sexual risk taking in young adulthood: a birth cohort study..
46:1272-1279.
2007
-
Fast track randomized controlled trial to prevent externalizing psychiatric disorders: findings from grades 3 to 9..
46:1250-1262.
2007
-
Predicting prognosis for the conduct-problem boy: can family history help?.
46:1240-1249.
2007
-
A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children..
46:1204-1212.
2007
-
AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry..
46:1098-1110.
2007
-
3-year follow-up of the NIMH MTA study..
46:989-1002.
2007
-
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects..
46:1028-1040.
2007
-
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up..
46:1015-1027.
2007
-
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses..
46:1003-1014.
2007
-
Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS)..
46:801-810.
2007
-
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder..
46:667-686.
2007
-
A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS)..
46:573-581.
2007
-
Reading problems, psychiatric disorders, and functional impairment from mid- to late adolescence..
46:25-32.
2007
-
Acute time to response in the Treatment for Adolescents with Depression Study (TADS)..
45:1412-1418.
2006
-
Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS)..
45:1419-1426.
2006
-
Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS)..
45:1427-1439.
2006
-
Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)..
45:1404-1411.
2006
-
The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks..
45:1393-1403.
2006
-
Treatment for Adolescents with Depression Study (TADS): safety results..
45:1440-1455.
2006
-
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD..
45:1284-1293.
2006
-
Pharmacogenetics of methylphenidate response in preschoolers with ADHD..
45:1314-1322.
2006
-
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS)..
45:1275-1283.
2006
-
Safety and tolerability of methylphenidate in preschool children with ADHD..
45:1294-1303.
2006
-
Stimulant-related reductions of growth rates in the PATS..
45:1304-1313.
2006
-
Test-Retest Reliability of the Preschool Age Psychiatric Assessment (PAPA)..
45:538-549.
2006
-
Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder..
45:422-430.
2006
-
Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government..
45:261-270.
2006
-
10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology..
45:8-25.
2006
-
Pharmacological management of preschool ADHD..
45:115-118.
2006
-
10-year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden..
44:972-986.
2005
-
CBT VERSUS SUPPORTIVE THERAPY FOR DEPRESSION.
44:842-843.
2005
-
CBT versus supportive therapy for depression..
44:841.
2005
-
The genetic and environmental contributions to oppositional defiant behavior: a multi-informant twin study..
44:907-914.
2005
-
Cumulative prevalence of psychiatric disorder in youths..
44:406-407.
2005
-
The influence of maternal stress and distress on disruptive behavior problems in boys..
44:265-273.
2005
-
The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics..
44:28-40.
2005
-
Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology..
43:1488-1496.
2004
-
The services for children and adolescents-parent interview: development and performance characteristics..
43:1334-1344.
2004
-
Inhalant abuse and dependence among adolescents in the United States..
43:1206-1214.
2004
-
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology..
43:1046-1056.
2004
-
Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review..
43:930-959.
2004
-
Mental health need and access to mental health services by youths involved with child welfare: a national survey..
43:960-970.
2004
-
The Child and Adolescent Psychiatry Trials Network (CAPTN)..
43:515-518.
2004
-
Informant disagreement for separation anxiety disorder..
43:452-460.
2004
-
Neural correlates of facial affect processing in children and adolescents with autism spectrum disorder..
43:481-490.
2004
-
Detection and outcomes of substance use disorders in adolescents seeking mental health treatment..
42:1318-1326.
2003
-
Mental health assessments in juvenile justice: report on the consensus conference..
42:752-761.
2003
-
School refusal and psychiatric disorders: a community study..
42:797-807.
2003
-
Cognitive-behavioral intervention for depressed, substance-abusing adolescents: development and pilot testing..
42:656-665.
2003
-
Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods..
42:531-542.
2003
-
Genetic influences on childhood competencies: a twin study..
42:357-363.
2003
-
Rates and predictors of aftercare services among formerly hospitalized adolescents: a prospective naturalistic study..
42:49-56.
2003
-
Searching for Moderators and Mediators of Pharmacological Treatment Effects in Children and Adolescents With Anxiety Disorders.
42:13-21.
2003
-
A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism..
41:1315-1321.
2002
-
Influence of adult domestic violence on children's internalizing and externalizing problems: an environmentally informative twin study..
41:1095-1103.
2002
-
The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties..
41:1061-1069.
2002
-
Oral flower essences for ADHD..
41:895.
2002
-
Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution..
41:498-504.
2002
-
Socioeconomic status as a moderator of ADHD treatment outcomes..
41:269-277.
2002
-
Adderall, the atypicals, and weight gain..
40:620.
2001
-
Sertraline in children and adolescents with social anxiety disorder: an open trial..
40:564-571.
2001
-
Measuring outcomes of care for adolescents with emotional and behavioral problems..
40:315-324.
2001
-
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups..
40:147-158.
2001
-
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment..
40:168-179.
2001
-
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial..
40:180-187.
2001
-
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis..
40:159-167.
2001
-
Symptom profiles in children with ADHD: effects of comorbidity and gender..
40:137-146.
2001
-
Cognitive risk factors and suicide attempts among formerly hospitalized adolescents: a prospective naturalistic study..
40:91-99.
2001
-
Effectiveness of mental health services.
40:3-4.
2001
-
Effectiveness of mental health services..
40:2-4.
2001
-
Fluvoxamine and enuresis..
39:1464-1466.
2000
-
Implications of early versus late onset of attention-deficit/hyperactivity disorder symptoms..
39:1512-1519.
2000
-
Toward a level playing field: predictive factors for the outcomes of mental health treatment for adolescents..
39:1485-1495.
2000
-
Naltrexone treatment of self-injurious behavior..
39:1076-1078.
2000
-
Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents..
39:1040-1046.
2000
-
Stimulant treatment for children: a community perspective..
39:975-984.
2000
-
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder..
39:713-720.
2000
-
Effectiveness of nonresidential specialty mental health services for children and adolescents in the "real world"..
39:154-160.
2000
-
Fluvoxamine and enuresis.
39:1465-1466.
2000
-
Naltrexone treatment of self-injurious behavior.
39:1077-1078.
2000
-
Priapism associated with venlafaxine use..
39:16-17.
2000
-
The Child and Adolescent Psychiatric Assessment (CAPA)..
39:39-48.
2000
-
Outcome at 6 months for 50 adolescents with major depression treated in a health maintenance organization..
38:1340-1346.
1999
-
Posttraumatic stress responses in bereaved children after the Oklahoma City bombing..
38:1372-1379.
1999
-
Nutritional supplements in ADHD..
38:1209-1211.
1999
-
Impulsivity and suicide..
38:939-940.
1999
-
Appetite and weight in children treated for ADHD..
38:792-793.
1999
-
Dystonia as a side effect of nonneuroleptics..
38:793-795.
1999
-
Somatic complaints and psychopathology in children and adolescents: stomach aches, musculoskeletal pains, and headaches..
38:852-860.
1999
-
Suicide attempts among formerly hospitalized adolescents: a prospective naturalistic study of risk during the first 5 years after discharge..
38:660-671.
1999
-
Absence of cardiovascular adverse effects of sertraline in children and adolescents..
38:573-577.
1999
-
Adolescent outcomes of childhood disorders: the consequences of severity and impairment..
38:121-128.
1999
-
Impaired but undiagnosed..
38:129-137.
1999
-
Comment by Dr. Horrigan, at the invitation of the editor.
38:1210-1211.
1999
-
Commentary on: Prevalence and impact of parent-reported disabling mental health conditions among U.S. children".
38:610-613.
1999
-
Dr. Horrigttn replies.
38:3.
1999
-
Dystonia as a side effect of nonneuroleptics.
38:794-795.
1999
-
Seizure associated with bupropion and guanfacine..
38:2-3.
1999
-
Diet and the atypical neuroleptics..
37:1126-1127.
1998
-
Headaches and psychopathology in children and adolescents..
37:951-958.
1998
-
Psychiatric diagnoses of previous suicide attempters, first-time attempters, and repeat attempters on an adolescent inpatient psychiatry unit..
37:924-932.
1998
-
Bupropion and guanfacine..
37:682-683.
1998
-
Adult physical health outcomes of adolescent girls with conduct disorder, depression, and anxiety..
37:594-601.
1998
-
Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor..
37:585-593.
1998
-
Erratum: Suicidal ideation and behavior and noncompliance with the medical regimen among diabetic adolescents (Journal of American Academy of Child And Adolescent 36 (1528-1536)).
37:795.
1998
-
Suicidal ideation and behavior and noncompliance with the medical regimen among diabetic adolescents..
36:1528-1536.
1997
-
Olanzapine in PDD..
36:1166-1167.
1997
-
More on melatonin..
36:1013.
1997
-
More on melatonin..
36:1014.
1997
-
Posttraumatic symptomatology in children and adolescents after an industrial fire..
36:1080-1088.
1997
-
Recurrence of major depressive disorder in hospitalized children and adolescents..
36:785-792.
1997
-
ADHD and EEG..
36:575-577.
1997
-
Letter to editor.
36:1014.
1997
-
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers..
35:1304-1313.
1996
-
Toward establishing an empirical basis for the diagnosis of oppositional defiant disorder..
35:1205-1212.
1996
-
Guanfacine for PTSD nightmares..
35:975-976.
1996
-
Outcomes of mental health care for children and adolescents: I. A comprehensive conceptual model..
35:1055-1063.
1996
-
First-time suicide attempters, repeat attempters, and previous attempters on an adolescent inpatient psychiatry unit..
35:631-639.
1996
-
Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors..
34:1424-1431.
1995
-
Epidemiology and health care reform..
33:1058-1059.
1994
-
Paroxetine-pimozide drug interaction..
33:1060-1061.
1994
-
Suicidal ideation and suicide attempts among youth with insulin-dependent diabetes mellitus..
33:240-246.
1994
-
An emerging schizophrenic syndrome..
32:1295-1301.
1993
-
How can epidemiology improve mental health services for children and adolescents?.
32:1106-1114.
1993
-
TCA toxicity..
32:1307-1308.
1993
-
Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation..
32:8-20.
1993
-
Use of inpatient services by a national population: do benefits make a difference?.
32:144-152.
1993
-
Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus..
31:1112-1119.
1992
-
A binational school survey of depressive symptoms, drug use, and suicidal ideation..
31:669-678.
1992
-
Massage reduces anxiety in child and adolescent psychiatric patients..
31:125-131.
1992
-
Cognitive and social cognitive development of depressed children and adolescents..
30:388-392.
1991
-
Mental health service use by adolescents in the 1970s and 1980s..
30:144-150.
1991
-
Reflections on stillness: mothers' reactions to the still-face situation..
30:22-28.
1991
-
The effects of age and sex on depression ratings in children and adolescents..
30:67-74.
1991
-
Internal consistency of DSM-III diagnoses using the symptom scales of the Child Assessment Schedule..
29:635-641.
1990
-
The pediatrician as gatekeeper to mental health care for children: do parents' concerns open the gate?.
29:453-458.
1990
-
Developmental implications of changing trajectories of IQ in males with fragile X syndrome..
29:214-219.
1990
-
Child psychiatric disorders and their correlates: a primary care pediatric sample..
28:851-855.
1989
-
Developments in child psychiatric epidemiology..
28:836-841.
1989
-
More on treated incidence data..
28:803-804.
1989
-
Control-related cognitions and depression among inpatient children and adolescents..
28:358-363.
1989
-
Scales to assess child and adolescent depression: checklists, screens, and nets..
27:726-737.
1988
-
Adaptations of cognitive therapy for depressed adolescents..
27:381-386.
1988
-
Neuropsychological deficit and self-reported delinquency in an unselected birth cohort..
27:233-240.
1988
-
Neuropsychological deficit and self-reported delinquency in an unselected birth cohort..
27:233-240.
1988
-
Violent or assaultive youth: dimensional and categorical comparisons with mental health samples..
27:226-232.
1988
-
3.36 The Prevalence and Nature of Developmental Concerns Evident Prior to Receiving a Positive ASD Screening in Primary Care
2022
-
3.40 Eye-Tracking Biomarkers of Social Attention Are Related to Naturalistic Social Interactions in Children With ASD
2022
-
3.43 More Severe Executive Function Impairments Are Associated With Increases in Frontal Theta and Decreases in Beta and Gamma EEG Power in Young Children With ASD
2022
-
3.49 Multimethod Examination of Congruence of Parent-Youth Report of Social Anxiety, Internalizing, and Externalizing Symptoms in Teens With ASD vs Social Anxiety and Typically Developing Controls
2022
-
58.4 Perinatal and Child Psychiatry Access Programs in North Carolina: Opportunities for Synergy to Augment Family Services
2022
-
CHILD WELFARE INTERVENTIONS AND SYSTEM TRANSFORMATION TO IMPROVE THE LIVES OF CHILDREN AND FAMILIES WHO EXPERIENCE TRAUMA
2022
-
HARNESSING CHILD AND ADOLESCENT PSYCHIATRY EXPERTISE THROUGH BEHAVIORAL HEALTH EDUCATION IN COLLABORATIVE CARE PROGRAMS AND PEDIATRICS RESIDENCY TRAINING INTERVENTIONS
2022
-
36.3 PERSONALITY TRAITS AND COPING DURING THE COVID-19 PANDEMIC
2021
-
39.1 Narcolepsy Comorbid With Mood Disorders in Adolescents: Clinical Correlates and Their Impact on Hospital Outcomes in the United States
2021
-
5.22 Improving the Predictive Value of Self-Report in Adult ADHD Diagnosis
2021
-
6.28 Identifying Networks Underlying Sleep Disruption in Autism Spectrum Disorder Mouse Models
2021
-
DIFFERENCES IN CLINICAL CHARACTERISTICS AND HOSPITALIZATION OUTCOMES IN ADOLESCENTS WITH SUBSTANCE-INDUCED PSYCHOSIS AND PRIMARY PSYCHOTIC DISORDERS: A CROSS-NATIONAL INPATIENT STUDY
2021
-
PIVOTING WITH THE PANDEMIC: CHALLENGES AND SUCCESSES OF CHILD PSYCHIATRY ACCESS PROGRAMS NATIONWIDE
2021
-
11.3 FAMILY PARTNERS: A PARENT-TO-PARENT PEER-SUPPORT MODEL UTILIZED WITHIN INPATIENT AND OUTPATIENT SETTINGS
2020
-
42.2 CANNABIS ABUSE LEADING TO HOSPITALIZATION FOR SEXUALLY TRANSMITTED INFECTIONS IN AMERICAN YOUTH: A NATIONAL INPATIENT CROSS-SECTIONAL STUDY
2020
-
5.10 EFFICACY AND SAFETY OF AN EXTENDED-RELEASE, ORALLY DISINTEGRATING METHYLPHENIDATE TABLET IN CHILDREN 6-12 YEARS OF AGE BASED ON ADHD RATING SCALE-IV SCORE AT BASELINE
2020
-
5.13 EXPLORING ENGAGEMENT AS A FACTOR FOR EFFICACY WITH AKL-T01, A HOME-BASED DIGITAL THERAPEUTIC
2020
-
5.25 STARS-ADJUNCT: A HOME-BASED, DIGITAL TREATMENT FOR PEDIATRIC ADHD AS ADJUNCT TO STIMULANT MEDICATION: INSIGHTS ON REPEAT ADMINISTRATION AND THE STABILITY OF EFFECTS
2020
-
5.26 STARS-ADJUNCT: AKL-T01, A DIGITAL TREATMENT FOR PEDIATRIC ADHD AS AN ADJUNCT TO STIMULANT MEDICATION: RESPONSE RATES WITH REPEAT ADMINISTRATION
2020
-
5.27 STARS-ADJUNCT: AKL-T01, A HOME-BASED DIGITAL INTERVENTION AS AN ADJUNCT TO STIMULANT MEDICATION FOR PEDIATRIC ADHD: ACADEMIC PERFORMANCE AND RELATION TO OBJECTIVE MEASURES OF ATTENTION
2020
-
5.6 NEUROMODULATION IN CHILDREN AND ADOLESCENTS: THE DEVIL IS IN THE DOSING
2020
-
BUILDING PROGRAMS THAT INCREASE ACCESS TO MENTAL HEALTH CARE FOR CHILDREN AND YOUTH, WHILE EXPANDING THE EVIDENCE BASE TO ENHANCE ACCESS AND IMPROVE DIAGNOSIS AND TREATMENT
2020
-
1.14 GRAPH CURVATURE AS A METHOD FOR DISCERNING ROBUSTNESS IN BRAIN NETWORKS IN ASD
2019
-
1.3 ONLINE PARENT TRAINING FOR DISRUPTIVE BEHAVIORS: INCREASING ACCESS TO CARE
2019
-
2.1 ASD AND INTELLECTUAL DISABILITY IN SPECIAL EDUCATION IN NORTH CAROLINA: ROLES OF RACE AND ECONOMIC DISADVANTAGE
2019
-
2.14 HEROIN OVERDOSE-RELATED CHILD AND ADOLESCENT HOSPITALIZATIONS: INSIGHT ON COMORBID PSYCHIATRIC AND SUBSTANCE USE DISORDERS
2019
-
2.3 BEHCET’S TO SJOGREN’S: THE ABCS OF AUTOIMMUNE BRAIN DISORDERS
2019
-
2.56 UNWINDING ANXIETY: USING TECHNOLOGY TO PROMOTE MENTAL HEALTH IN COLLEGE STUDENTS
2019
-
27.1 NEURAL STRUCTURE IS INDEPENDENTLY PREDICTED BY DEPRIVATION AND THREAT IN EARLY CHILDHOOD
2019
-
27.3 ASSOCIATIONS OF CHILDHOOD THREAT AND DEPRIVATION ON ADULT PSYCHIATRIC DISORDERS AND FUNCTIONAL OUTCOMES
2019
-
37.4 COMPUTER-BASED AND PARENT-REPORTED ASSESSMENT OF EXECUTIVE FUNCTIONING: METHOD VARIANCE AND IMPLICATIONS FOR INTERPRETING FINDINGS FROM ADHD EFFICACY TRIALS
2019
-
4.14 CONDUCT DISORDER-RELATED HOSPITALIZATION AND SUBSTANCE USE DISORDERS IN AMERICAN TEENS
2019
-
4.2 RCT OF THE VERMONT FAMILY-BASED APPROACH (VFBA) IN PRIMARY CARE PEDIATRICS: ENGAGEMENT WITH HEALTH AND SUPPORT SERVICES
2019
-
4.57 EXAMINING TRENDS IN MOOD IN RELATION TO DAILY WELLNESS AND RISK BEHAVIORS IN A COLLEGE STUDENT POPULATION
2019
-
4.60 WELLNESS ENVIRONMENT HEALTH PROMOTION APP STUDY: LONGITUDINAL TRENDS IN ADULT SELF-REPORT SUBSCALE SCORES
2019
-
4.61 MOOD AND WELLNESS-RELATED BEHAVIORS IN THE UNIVERSITY OF VERMONT WELLNESS ENVIRONMENT: ANALYSIS OF BIDIRECTIONAL LONGITUDINAL RELATIONS
2019
-
6.21 TRAJECTORIES OF RELIGIOUS DEVELOPMENT AND CORRELATIONS WITH MENTAL HEALTH FROM ADOLESCENCE TO ADULTHOOD
2019
-
6.37 EFFECT OF THE HARMONY PROJECT MUSIC INSTRUCTION PROGRAM ON ACADEMIC OUTCOMES IN ELEMENTARY SCHOOL STUDENTS
2019
-
6.61 ADHD AND SUBSTANCE USE DISORDERS: AN ANALYSIS OF 0.8 MILLION ADOLESCENT INPATIENTS
2019
-
Duration of Effect of a Novel, Home-Based, Digital Treatment for Pediatric ADHD
2019
-
IDENTIFYING DISPARITIES AND IMPLEMENTING NOVEL INTERVENTIONS TO OVERCOME INEQUITIES IN ASD
2019
-
RELATIONSHIP BETWEEN SENSORY PROCESSING DIFFERENCES AND CLINICAL FEATURES OF CHILDREN WITH ASD
2019
-
SCREENING TOOLS IN THE EMERGENCY DEPARTMENT
2019
-
1.31 The Utility of Electroencephalogram (EEG) Beta Power as a Moderator of Treatment Response in ASD Clinical Trials Involving Young Children
2018
-
1.44 Efficacy of Pharmacogenomic Testing in Child and Adolescent Outpatient Practice
2018
-
16.4 Treatment Approaches in the Management of Autoimmune Encephalopathy
2018
-
2.22 Lisdexamfetamine Dimesylate for Preschool Children With ADHD
2018
-
2.40 A Multicenter, Randomized, Active-Control Registration Trial of Software Treatment for Actively Reducing Severity of ADHD (Stars-Adhd) to Assess the Efficacy and Safety of a Novel, Home-Based, Digital Treatment for Pediatric ADHD
2018
-
23.1 Autism and Beyond: Lessons From an Iphone Study of Young Children
2018
-
23.4 Creating Early-Childhood Research Tools That Families Want to Use: The When to Wonder Platform
2018
-
35.2 Adult Outcomes of ICD-10 Hyperkinetic Disorder in the MTA and Effect of Comorbidity
2018
-
35.3 Adolescent Depression: Concurrent and Prospective Associations With Substance Use Risk in Adolescence and Young Adulthood in the MTA
2018
-
4.15 The Efficacy and Safety of Methylphenidate Hydrochloride (HCL) Extended-Release in Preschool Aged Children With ADHD
2018
-
4.36 Identification of Clinical Phenotypes Within Seropositive Autoimmune Encephalitis Among Children and Adolescents
2018
-
4.37 Evaluation of Diagnostic Criteria for Hashimoto's Encephalopathy in Children and Adolescents
2018
-
5.18 A Scalable Off-the-Shelf Framework for Measuring Children’s Direction of Attention in ASD
2018
-
5.29 Differences in Demographic and Inpatient Outcomes in Hospitalized Autistic Teens With ADHD: A Nationwide Case-Control Study
2018
-
6.11 Is Cannabis Use Associated With Worse Inpatient Outcomes in Adolescents With ADHD?
2018
-
6.39 Inpatient Treatment of Children and Adolescents With Antipsychotics: Insights From a Nationwide Case-Control Study
2018
-
6.43 Reducing Repeat Emergency Department Visits Among Pediatric Patients With Mental Health Concerns: Providing Rapid Access to Outpatient Follow-Up Care
2018
-
1.21 Practices to Facilitate the Acquisition of Electrophysiological Data in Children With Autism Spectrum Disorder and Their Impact on Reducing Data Attrition
2017
-
11.0 Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS)
2017
-
21.2 Substance Use Among Children With and Without Attention-Deficit/Hyperactivity Disorder Followed Prospectively Into Early Adulthood in the MTA
2017
-
21.3 The MTA Qualitative Interview Study of Persistent and Non-Persistent Substance Use: Sample Selection, Demographic Characteristics, and Effects of Treatment and Natural History of the Disorder
2017
-
21.4 Turning Points in the Lives of Youth of With/Without Attention-Deficit/Hyperactivity Disorder: Are They Linked to Changes in Substance Use?
2017
-
23.4 Treatment Considerations in Autoimmune Encephalopathy
2017
-
3.31 Building Predictive Models for Autism Spectrum Disorder Based on Biosensor Data
2017
-
4.13 Validity of Automated Methods for Assessing Child Communication Abilities (LENA) in an Autism Clinical Trial
2017
-
5.16 AMO-01 in the SHANK3 Knockout Transgenic Mouse Model of Phelan Mcdermid Syndrome
2017
-
5.24 Associations Between Behavioral Comorbidities in Young Children With Autism Spectrum Disorder and Parenting Stress
2017
-
5.30 Prospective, Observational Cohort Study of Jake®, an Autism Knowledge Engine: Correlation of Behavior Ratings With Eye Tracking
2017
-
6.67 Cognitive-Behavioral Therapy (CBT) for Children With Anxiety Disorder: Do the Therapists’ Adherence and Competence Matter?
2017
-
1.23 THE UTILITY OF OBJECTIVE MEASURES OF SOCIAL COMMUNICATION DEFICITS IN YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDER
2016
-
14.3 Leveraging Technology to Support Training, Treatment Adherence, and Outcomes
2016
-
21.0 Abnormal Neural Substrate for Performance Monitoring in Pediatric Obsessive-Compulsive Disorder: Implications for Understanding Treatment Response
2016
-
21.1 COGNITIVE-BEHAVIORAL THERAPY–BASED CHANGES IN CONTROL AND REWARD CIRCUITS IN PEDIATRIC OBSESSIVE-COMPULSIVE DISORDER
2016
-
3.21 DSM-5 ANXIETY DISORDERS AMONG YOUNG ADULTS IN THE UNITED STATES
2016
-
4.9 EMERGENCY DEPARTMENT UTILIZATION IS INCREASED BY FOSTER CARE AND POLYPHARMACY
2016
-
47.0 Bringing Evidence-Based Treatment to Emerging Adults With Anxiety Disorders in Three Clinical Settings: The Youth Anxiety Center
2016
-
47.1 THE PROMISE OF ELECTROENCEPHALOGRAPHY, EYE TRACKING, AND NEUROIMAGING MEASURES FOR USE IN AUTISM SPECTRUM DISORDER CLINICAL TRIALS
2016
-
6.41 A SIX-MONTH OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF PRC-063 IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
2016
-
6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
2016
-
6.80 PLACEBO RESPONSE IN PEDIATRIC ANXIETY DISORDERS: RESULTS FROM THE CHILD AND ADOLESCENT ANXIETY MULTIMODAL STUDY
2016
-
8.1 Disruptive Mood Dysregulation Disorder in Children With Autism Spectrum Disorder
2016
-
9.0 Research Symposium: Behavioral Neuroscience
2016
-
Interpersonal Psychotherapy for Depression: Understanding the Core of the Interpersonal Psychotherapy for Depressed Adolescents Model and Its Adaptations
2016